×
Hero Background

Gout Companies

ID: MRFR/HC/4453-CR
128 Pages
Rahul Gotadki
August 2023

Gout companies lead the charge in addressing this inflammatory arthritis through innovative solutions. Specializing in research, development, and distribution, they provide advanced treatments, contributing to improved management and quality of life for individuals affected by gout.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Gout Market Research Report—Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Gout Market

Gout Market

 


Latest Gout Companies Updates:


Akash Patel, Pharma Analyst at GlobalData, highlights: "Projected for a 2025 release in Japan, Dotinurad, a pediatric URAT1 inhibitor, is set to debut alongside pegdricase, a recombinant enzyme therapy, launching new options for early diagnosis and treatment."


Sun Pharma: Launched their Febuxostat generic version in India, making the medication more affordable and accessible.Mylan: Received FDA approval for their allopurinol chewable tablets, catering to patients with difficulty swallowing.


Horizon Pharma: Partnered with Viela Bio to commercialize pegloticase in the US, expanding treatment options for severe gout.CymaBay Therapeutics: Their S8885 compound is in Phase 3 clinical trials, holding promise for a novel urate-lowering therapy with potentially fewer side effects.


List of Gout companies in the market:



  • Novartis AG (Switzerland)

  • Lannett (US)

  • Horizon Therapeutics plc (US)

  • Takeda Pharmaceutical Company Limited (Japan)

  • GlaxoSmithKline plc (UK)

  • Regeneron Pharmaceuticals, Inc (US)

  • Teijin Limited (Japan)

  • Viatris Inc (US)

  • Boehringer Ingelheim International GmbH (Germany)

  • ROMEG Therapeutics, LLC (US)